Tustin, CA - Integrium Executives will be in Orlando during the 2017 GPhA Annual Meeting. We are eager and excited to see friends and discover new relationships in the Generic / Biosimilars / 505(b)(2) industry. Integrium is heavily involved in the generic drug sector and is interested in hearing from key note speakers as to how the generic industry continues to rapidly change and impact healthcare customers as a whole.
Integrium Executives find GPhA to be a great time to connect and learn more about the generic drug field and expand their network within areas that are most critical in the healthcare industry. Having access to affordable medicine is important for many consumers in the U.S. and beyond, making GPhA an opportunity for many life science executives to gain access to why generics make the world go round.
Integrium will be scheduling meetings all day on Tuesday, February 14th, 2017 at the JW Marriott Orlando Grande Lakes, 4040 Central Florida Pkwy, Orlando, FL 32837.
To reserve a time slot to meet with Integrium, click the registration button below to contact Emily MacHale, Associate Director of Marketing & Research:
Integrium helps Micro Cap, Small Cap, and Privately held Biotechs within the Generic and Innovator space attain clinical data so they can raise the next round of capital. Integrium’s areas of therapeutic focus include Cardiovascular, Metabolic, Renal, Inflammatory, Dermatology, Wound Healing, Gene Therapy, and Orphan Diseases. Secondary specialties include Schedule 2 drugs and Oncology
To learn more about Integrium, contact:
Associate Director of Marketing & Research